OpenAlex
PricingAboutJobs
Log inGet started
Work

The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review

HTML

Year: 2018
Type: review
Source: European Journal of Medicinal Chemistry
DOI: 10.1016/j.ejmech.2018.03.062
Authors: Chengyuan Liang, Danni Tian, Xiaodong Ren, Shunjun Ding, Minyi Jia, Minhang Xin, Suresh Thareja
Institutions: Shaanxi University of Science and Technology, Guizhou Provincial People's Hospital, Xi'an Jiaotong University, Guru Ghasidas Vishwavidyalaya
Language: English

Topic: Chronic Lymphocytic Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: Bruton's tyrosine kinase, BTK inhibitors, small-molecule kinase inhibitors, irreversible inhibitors, reversible inhibitors, covalent inhibitors, structure-activity relationship, binding mode, hematologic malignancies, off-target effects
SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, China Postdoctoral Science Foundation
Awards: G3896425635, G4401916340
OpenAlex ID: W2791441078
FWCI: 3.409
Cites: 112
Cited by: 180
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security